What is the primary strategic rationale behind Stryker's acquisition of K2M?

The acquisition of K2M is driven by Stryker's strategy to expand its surgical solutions portfolio, specifically by strengthening its presence in the growing market for complex spine and minimally invasive spine technologies. K2M's expertise and product offerings are expected to complement Stryker's existing business.

What is the total value of the K2M acquisition?

The total equity value for the transaction is approximately $1.4 billion.

What conditions must be met for the merger to be completed?

The merger's consummation is subject to several conditions, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, receipt of required foreign competition law approvals, affirmative vote of a majority of K2M's outstanding common stock, and other customary closing conditions.

What happens to K2M shareholders upon completion of the merger?

Each share of K2M common stock outstanding immediately before the merger will be converted into the right to receive $27.50 in cash.

SYK 8-K: Material Agreements & Regulation FD

Summary

Stryker Corporation has announced a significant strategic move by entering into a definitive agreement to acquire K2M Group Holdings, Inc. The acquisition, valued at approximately $1.4 billion, will be executed through a merger where K2M will become a wholly owned subsidiary of Stryker. This deal is set to bolster Stryker's offerings in the complex spine and minimally invasive spine technologies market, aligning with their strategy to expand their surgical solutions portfolio. The transaction is expected to be an all-cash deal, with K2M shareholders receiving $27.50 per share. The consummation of the merger is contingent upon customary closing conditions, including antitrust approvals under the Hart-Scott-Rodino Act and foreign competition laws, as well as K2M shareholder approval. The acquisition is poised to enhance Stryker's competitive position in a growing segment of the medical device industry.

Key Highlights

1Stryker to acquire K2M Group Holdings, Inc. for approximately $1.4 billion.
2The transaction will be an all-cash deal, with K2M shareholders receiving $27.50 per share.
3K2M specializes in complex spine and minimally invasive spine technologies.
4The acquisition is expected to strengthen Stryker's position in the spine market.
5Closing of the merger is subject to regulatory approvals (including HSR Act) and K2M shareholder vote.
6A termination fee of $47.6 million is payable by K2M to Stryker under certain circumstances.

STRYKER CORP 8-K Report, Material Agreement (Aug 30, 2018)

Summary

Key Highlights

Frequently Asked Questions